References
- Modlin IM, Lewis JJ, Ahlman H, Bilchik AJ, Kumar RR. Management of unresectable malignant endocrine tumors of the pancreas. Surg Gynecol Obstet 1993;176:507-518.
- Grier JF. WDHA (watery diarrhea, hypokalemia, achlorhydria) syndrome: clinical features, diagnosis, and treatment. South Med J 1995;88:22-24. https://doi.org/10.1097/00007611-199501000-00002
- Smith SL, Branton SA, Avino AJ, et al. Vasoactive intestinal polypeptide secreting islet cell tumors: a 15-year experience and review of the literature. Surgery 1998;124:1050-1055. https://doi.org/10.1067/msy.1998.92005
- Remme CA, de Groot GH, Schrijver G. Diagnosis and treatment of VIPoma in a female patient. Eur J Gastroenterol Hepatol 2006;18:93-99. https://doi.org/10.1097/00042737-200601000-00017
- Case CC, Wirfel K, Vassilopoulou-Sellin R. Vasoactive intestinal polypeptide-secreting tumor (VIPoma) with liver metastases: dramatic and durable symptomatic benefit from hepatic artery embolization, a case report. Med Oncol 2002;19:181-187. https://doi.org/10.1385/MO:19:3:181
- Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216. https://doi.org/10.1093/jnci/92.3.205
- Marlink RG, Lokich JJ, Robins JR, Clouse ME. Hepatic arterial embolization for metastatic hormone-secreting tumors: technique, effectiveness, and complications. Cancer 1990;65:2227-2232. https://doi.org/10.1002/1097-0142(19900515)65:10<2227::AID-CNCR2820651011>3.0.CO;2-C
- Ito S, Kasturagi M, Otsuji H, et al. Transcatheter embolization of metastatic liver VIPoma: report of a case. Rinsho Hoshasen 1987;32:1169-1172.
- Ajani JA, Carrasco CH, Wallace S. Neuroendocrine tumors metastatic to the liver: vascular occlusion therapy. Ann N Y Acad Sci 1994;733:479-487. https://doi.org/10.1111/j.1749-6632.1994.tb17298.x
- Nguyen HN, Backes B, Lammert F, et al. Long-term survival after diagnosis of hepatic metastatic VIPoma: report of two cases with disparate courses and review of therapeutic options. Dig Dis Sci 1999;44:1148-1155. https://doi.org/10.1023/A:1026672022917
- Moertel CG, Lefkopoulo M, Lipsitz S, Hahn RG, Klaassen D. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 1992;326:519-523. https://doi.org/10.1056/NEJM199202203260804
- Fjallskog ML, Granberg DP, Welin SL, et al. Treatment with cisplatin and etoposide in patients with neuroendocrine tumors. Cancer 2001;92:1101-1107. https://doi.org/10.1002/1097-0142(20010901)92:5<1101::AID-CNCR1426>3.0.CO;2-V
- Wymenga AN, Eriksson B, Salmela PI, et al. Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms. J Clin Oncol 1999;17:1111. https://doi.org/10.1200/JCO.1999.17.4.1111
- Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008;9:61-72. https://doi.org/10.1016/S1470-2045(07)70410-2
- Khanna G, O'Dorisio SM, Menda Y, Kirby P, Kao S, Sato Y. Gastroenteropancreatic neuroendocrine tumors in children and young adults. Pediatr Radiol 2008;38:251-259.
- Thomason JW, Martin RS, Fincher ME. Somatostatin receptor scintigraphy: the definitive technique for characterizing vasoactive intestinal peptide-secreting tumors. Clin Nucl Med 2000;25:661-664. https://doi.org/10.1097/00003072-200009000-00001
- Peng SY, Li JT, Liu YB, et al. Diagnosis and treatment of VIPoma in China: (case report and 31 cases review) diagnosis and treatment of VIPoma. Pancreas 2004;28:93-97. https://doi.org/10.1097/00006676-200401000-00015